Novavax | NVAX - Ingresos Por Ventas





Ventas Cambio Fecha
Adma Biologics USD 114.5M 24.66M 2026-03
Agenus USD 34.2M 3.97M 2025-12
AstraZeneca USD 15.29B 213M 2026-03
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
Geron USD 51.84M 3.82M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
MannKind USD 90.2M 21.76M 2026-03
Merck USD 16.29B 110M 2026-03
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 389M 289M 2026-03
Novartis USD 13.11B 750M 2026-03
Novavax USD 147.14M 76.69M 2025-12
Pfizer USD 14.5B 3.08B 2026-03
Sanofi EUR 11.24B 60M 2026-03
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
TG Therapeutics USD 194.8M 2.23M 2026-03